JP5219818B2 - 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット - Google Patents

乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット Download PDF

Info

Publication number
JP5219818B2
JP5219818B2 JP2008536470A JP2008536470A JP5219818B2 JP 5219818 B2 JP5219818 B2 JP 5219818B2 JP 2008536470 A JP2008536470 A JP 2008536470A JP 2008536470 A JP2008536470 A JP 2008536470A JP 5219818 B2 JP5219818 B2 JP 5219818B2
Authority
JP
Japan
Prior art keywords
prdm14
gene
expression
expression level
ovarian cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008536470A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2008038832A1 (ja
Inventor
実 豊田
隆至 時野
公一 平田
紀子 西川
東生 大村
浩三 今井
Original Assignee
今井浩三
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 今井浩三 filed Critical 今井浩三
Priority to JP2008536470A priority Critical patent/JP5219818B2/ja
Publication of JPWO2008038832A1 publication Critical patent/JPWO2008038832A1/ja
Application granted granted Critical
Publication of JP5219818B2 publication Critical patent/JP5219818B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2008536470A 2006-09-27 2007-09-27 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット Active JP5219818B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008536470A JP5219818B2 (ja) 2006-09-27 2007-09-27 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006263232 2006-09-27
JP2006263232 2006-09-27
PCT/JP2007/069413 WO2008038832A1 (fr) 2006-09-27 2007-09-27 Agent thérapeutique, procédé de détection et kit de détection pour cancer du sein et cancer ovarien
JP2008536470A JP5219818B2 (ja) 2006-09-27 2007-09-27 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012253108A Division JP5395246B2 (ja) 2006-09-27 2012-11-19 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット

Publications (2)

Publication Number Publication Date
JPWO2008038832A1 JPWO2008038832A1 (ja) 2010-04-08
JP5219818B2 true JP5219818B2 (ja) 2013-06-26

Family

ID=39230258

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008536470A Active JP5219818B2 (ja) 2006-09-27 2007-09-27 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット
JP2012253108A Active JP5395246B2 (ja) 2006-09-27 2012-11-19 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012253108A Active JP5395246B2 (ja) 2006-09-27 2012-11-19 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット

Country Status (2)

Country Link
JP (2) JP5219818B2 (enrdf_load_stackoverflow)
WO (1) WO2008038832A1 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6683986B2 (ja) * 2013-07-10 2020-04-22 国立大学法人 東京大学 がん幹細胞分子マーカー
SG10201607303YA (en) 2016-09-01 2018-04-27 Agency Science Tech & Res Antisense oligonucleotides to induce exon skipping
JP6898617B2 (ja) * 2017-09-26 2021-07-07 国立大学法人 東京大学 Ｐｒｄｍ１４発現を確認する方法
EP3996684A4 (en) * 2019-07-09 2024-06-19 Ariz Precision Medicine, Inc. CANCER TREATMENT USING TARGETED PHARMACEUTICAL SIRNA FORMULATIONS TO DECREASE THE EXPRESSION OF THE PRDM14 PROTEIN
EP4150093A4 (en) 2020-05-14 2024-06-19 Ariz Precision Medicine, Inc. CANCER TREATMENT USING SIRNA TO MODULATE PRDM2/RICE PROTEIN EXPRESSION

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014173A1 (en) * 2001-07-18 2006-01-19 The Burnham Institute PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014173A1 (en) * 2001-07-18 2006-01-19 The Burnham Institute PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012048080; 西川紀子，　ｅｔ　ａｌ．: '乳癌におけるヒストンメチル化酵素ＰＲＤＭ１４遺伝子の発現上昇および遺伝子増幅' 日本癌学会学術総会記事 Ｖｏｌ．　６５ｔｈ, 20060828, ｐ．　１５４　（＃２２４） *
JPN6012048081; Ｈｕ　Ｍ，　ｅｔ　ａｌ．: 'Ｄｉｓｔｉｎｃｔ　ｅｐｉｇｅｎｅｔｉｃ　ｃｈａｎｇｅｓ　ｉｎ　ｔｈｅ　ｓｔｒｏｍａｌ　ｃｅｌｌｓ　ｏｆ　ｂｒｅａｓｔ　ｃａｎｃｅｒｓ' Ｎａｔｕｒｅ　Ｇｅｎｅｔｉｃｓ Ｖｏｌ．　３７，　Ｎｏ．　８, 200508, ｐ．　８９９-９０５ *

Also Published As

Publication number Publication date
JPWO2008038832A1 (ja) 2010-04-08
JP2013100286A (ja) 2013-05-23
WO2008038832A1 (fr) 2008-04-03
JP5395246B2 (ja) 2014-01-22

Similar Documents

Publication Publication Date Title
JP5589149B2 (ja) 癌に関与するポリヌクレオチド配列およびポリペプチド配列
EP2300041B1 (en) Method for determining risk of recurrence of prostate cancer
KR20150122786A (ko) 암 전이의 진단, 예후 및 치료를 위한 방법
JP5395246B2 (ja) 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット
AU2023203737B2 (en) Methods for diagnosing and treating metastatic cancer
JPWO2019093502A1 (ja) がん促進因子発現抑制剤、その有効成分のスクリーニング方法、該方法に有用な発現カセット、診断薬、及び診断方法
JP6683986B2 (ja) がん幹細胞分子マーカー
KR101133243B1 (ko) 암의 진단 및 치료를 위한 ｅＩＦ３ｍ의 용도
KR20230088634A (ko) 간암 특이적 바이오 마커 및 이의 용도
CN105189786A (zh) 用作治疗癌症的疗法的靶标的falz
JPWO2016152352A1 (ja) メラノーマ特異的バイオマーカー及びその利用
KR101875935B1 (ko) Ｈｅｒ2 저해제 내성 바이오마커
US11525008B2 (en) Methods and pharmaceutical compositions for the treatment of lung cancer
US20230272478A1 (en) Biomarker specific for liver cancer, and use thereof
WO2009084668A1 (ja) 癌細胞増殖阻害方法、増殖阻害剤及びスクリーニング方法
JP6839707B2 (ja) Ｇｐｒ１６０を過剰発現する癌の予防、診断および治療
WO2012034076A2 (en) Etv1 as a diagnostic, prognostic and therapeutic target for gastrointestinal stromal tumors
WO2008075713A1 (ja) 癌診断用マーカーならびに治療の標的分子
JP2005073548A (ja) 卵巣明細胞腺癌の検査、治療、および治療薬のスクリーニングのための、ＨＮＦ−１βの利用
JP2014014368A (ja) がんに特異的なバイオマーカー
WO2015099197A1 (ja) 肺癌の検査方法

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20091210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100927

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20100927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120918

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20121030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130305

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160315

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5219818

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250